Timber Pharmaceuticals Stock Price To Earnings To Growth
| TMBRDelisted Stock | USD 1.72 0.01 0.58% |
Timber Pharmaceuticals fundamentals help investors to digest information that contributes to Timber Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Timber Stock. The fundamental analysis module provides a way to measure Timber Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Timber Pharmaceuticals stock.
Timber |
Timber Pharmaceuticals Company Price To Earnings To Growth Analysis
Timber Pharmaceuticals' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Timber Pharmaceuticals has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Timber Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Timber Pharmaceuticals' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Timber Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Timber Pharmaceuticals by comparing valuation metrics of similar companies.Timber Pharmaceuticals is currently under evaluation in price to earnings to growth category among its peers.
Timber Fundamentals
| Return On Equity | -3.43 | |||
| Return On Asset | -1.37 | |||
| Current Valuation | (916.94 K) | |||
| Shares Outstanding | 3.43 M | |||
| Shares Owned By Insiders | 1.11 % | |||
| Shares Owned By Institutions | 7.78 % | |||
| Number Of Shares Shorted | 7.91 K | |||
| Price To Book | 6.94 X | |||
| Price To Sales | 17.19 X | |||
| Revenue | 83.18 K | |||
| Gross Profit | (5.26 M) | |||
| EBITDA | (19.16 M) | |||
| Net Income | (19.38 M) | |||
| Cash And Equivalents | 11.22 M | |||
| Cash Per Share | 3.78 X | |||
| Total Debt | 331.15 K | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 2.45 X | |||
| Book Value Per Share | (0.86) X | |||
| Cash Flow From Operations | (15.85 M) | |||
| Short Ratio | 0.21 X | |||
| Earnings Per Share | (1.97) X | |||
| Target Price | 11.0 | |||
| Beta | -0.65 | |||
| Market Capitalization | 1.18 M | |||
| Total Asset | 10.28 M | |||
| Retained Earnings | (48.26 M) | |||
| Working Capital | 4.77 M | |||
| Z Score | -10.03 | |||
| Net Asset | 10.28 M |
About Timber Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Timber Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Timber Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Timber Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Timber Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Timber Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Timber Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Timber Stock
Moving against Timber Stock
| 0.81 | KO | Coca Cola Sell-off Trend | PairCorr |
| 0.8 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.73 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.66 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.64 | PPERF | Bank Mandiri Persero | PairCorr |
The ability to find closely correlated positions to Timber Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Timber Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Timber Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Timber Pharmaceuticals to buy it.
The correlation of Timber Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Timber Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Timber Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Timber Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |